Disease management for co-morbid depression and anxiety in diabetes mellitus: design of a randomised controlled trial in primary care.

Abstract

BACKGROUND:

Depression and anxiety are common co-morbid health problems in patients with type 2 diabetes. Both depression and anxiety are associated with poor glycaemic control and increased risk of poor vascular outcomes and higher mortality rates. Results of previous studies have shown that in clinical practice, treatment of depression and anxiety is far from optimal as these symptoms are frequently overlooked and undertreated.

METHODS/DESIGN:

This randomised controlled trial will examine the effectiveness of a disease management programme treating symptoms of depression and anxiety in primary care patients with Type 2 diabetes. Patients will be randomized on patient level in 1:1 ratio. Random block sizes of 2 and 4 are used. The disease management programme consists of screening, stepped treatment and monitoring of symptoms (n = 80). This will be compared to care as usual (n = 80).

DISCUSSION:

The disease management model for co-morbid depression and anxiety in primary care patients with diabetes is expected to result in reduced symptoms of depression and anxiety, improved quality of life, reduced diabetes specific distress and improved glyceamic control, compared to care as usual.

TRIAL REGISTRATION:

Dutch Trial Register NTR2626.

• Authors: Corinne H Stoop, Viola R M Spek, Victor J M Pop, François Pouwer
• Journal: BMC family practice (BMC Fam Pract) Vol. 12 Pg. 139 (Dec 15 2011) ISSN: 1471-2296 [Electronic] England
• PMID: 22171804 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)

Topics

• Anxiety (complications, therapy)
• Depression (complications, therapy)
• Diabetes Complications (therapy)
• Diabetes Mellitus, Type 1 (complications, therapy)
• Disease Management
• Humans
• Primary Health Care